Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia
It is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
CCI commences consultation process for pharma study
The study is being done with a view to developing a better understanding of the competition landscape in the sector
Aurobindo Pharma receives USFDA nod for Droxidopa Capsules
The product will be launched immediately
Lupin gets US FDA approval for Droxidopa Capsules
The product will be manufactured at Lupin’s facility in Nagpur, India
Zydus Cadila gets final nod from USFDA for Droxidopa Capsules
It is indicated for use in people with conditions of the nervous system that can cause low blood pressure
Unichem Laboratories gets USFDA approval for Apremilast Tablets
Apremilast tablets are indicated for the treatment of plaque psoriasis
Eli Lilly enters into $960 million deal with Rigel Pharma to develop autoimmune therapy
Under the deal, Lilly will foot the costs of global commercialisation for the therapy, R552, and Rigel will have the right to…
Shilpa Medicare gets Import Alert from USFDA
Three products have been exempted from the Import Alert - Azacitidine for Injection, Cyclophosphamide Capsules and Erlotinib…
Quality, turn-around-times and cost are major pain points in life sciences, CRO and pharma…
Vinay Raj, VP, Reverie Language Technologies explains the need for transparency and reliability in the translation life cycle of…
Brexit deal offers UK access to research and innovation program worth €95.5 bn: GlobalData
The UK-EU trade deal will give the UK researchers and businesses access to Horizon Europe funding on equivalent terms as EU…
Dr Reddy’s launch Fluphenazine Hydrochloride Tablets in US
Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia
Antares Vision acquires rfXcel Corporation in $120 million deal
The acquisition of rfXcel is expected to strengthen Antares Vision Group’s software capabilities, consolidating its position as a…
Dr Reddy’s launch Capecitabine Tablets, USP in US
Capecitabine tablet is indicated for the treatment of Adjuvant Colon Cancer, Metastatic Colorectal Cancer and Metastatic Breast…
Granules India gets US FDA approval for Potassium Chloride ER Capsules
Potassium Chloride is indicated for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis…
Lupin launches Posaconazole Delayed-Release Tablets
They are indicated for prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing…
Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer
The company informs that the drug is priced 96 per cent lower than the innovator brand and reduces the risk of kidney cancer…
NPPA fixes retail prices of Vildagliptin 50 mg + Metformin Hydrochloride 500 mg and 1000 mg SR…
It has decided to fix the retail price as per the Price To Retailer (PTR) based on Form-V data submitted by the companies for whom…
Biocon Biologics partners with IDF to improve access to insulins
The partnership coincides with the start of the centenary celebrations of the discovery of insulin
LANXESS to acquire Emerald Kalama Chemical
The purchase price is around $1.04 billion, which LANXESS will finance from existing liquidity. The transaction is expected to be…
Lupin, Aurobindo recall drugs in US market
Lupin Pharma is recalling 46,479 bottles of Oseltamivir Phosphate for Oral Suspension while AuroMedics Pharma, a unit of Aurobindo…